STAAR Surgical Company (STAA) financial statements and ratios from SEC XBRL: revenue $0.3B (TTM), net margin -33.6%, revenue growth 111.0% YoY, P/E 298.3. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $239.44M |
| Revenue (TTM) | $0.3B |
| Net Margin | -33.6% |
| Operating Margin (TTM) | 4.0% |
| Revenue Growth (YoY) | 111.0% |
| EPS Growth (YoY) | -147.1% |
| FCF Growth (YoY) | -166.1% |
| P/E Ratio | 298.3 |
| EV / EBITDA | 45.2 |
| Price / Book | 3.13 |
| Price / Sales | 3.37 |
| FCF Yield | -3.5% |
| Altman Z-Score | 6.44 (safe) |
| Industry P/E (Medical Equipment) | 29.8 |
| Sector P/E (Healthcare) | 21.6 |
STAA overview · STAA earnings · STAA KPIs · STAA documents · STAA ownership · STAA peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.